Barry Quart appointed as CEO at Connect Biopharma

Home / Company news / Barry Quart appointed as CEO at Connect Biopharma

Congratulations to our client Connect Biopharma on their appointment of Barry Quart as Chief Executive Officer

Connect Biopharma is a global, clinical-stage biopharmaceutical company applying its expertise in T cell biology and deep knowledge of the drug discovery industry to develop innovative therapies to treat chronic inflammatory diseases with the goal of improving the lives of millions of those affected around the world. The Company is building a rich pipeline of proprietary small molecules and antibodies, using functional T cell assays, to screen and discover potent product candidates against validated immune targets.

C1 Team: Christos Richards and James Reynolds

Author